Heterogeneity of apolipoprotein B-100-containing lipoproteins: what we have learnt from kinetic studies
- PMID: 9645501
- DOI: 10.1097/00041433-199806000-00003
Heterogeneity of apolipoprotein B-100-containing lipoproteins: what we have learnt from kinetic studies
Abstract
Apolipoprotein B-100-containing lipoprotein assembly is dependent on the successive addition of triglyceride by microsomal transfer protein. Assembly may end at this point and the lipoprotein secreted or it may continue with the bulk addition of triglyceride by an unknown transfer process. These steps are independently regulated and result in the secretion of a spectrum of apolipoprotein B-100-containing particles. The production of small, dense LDL is determined by the type of VLDL secreted by the liver. Large, triglyceride-rich VLDL1 results in the formation of small, dense LDL through triglyceride exchange and subsequent hydrolysis. Small, dense LDL are cleared from plasma relatively slowly and tend to accumulate in the circulation where they exert their atherogenic effects.
Similar articles
-
Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.Atherosclerosis. 2002 Aug;163(2):287-96. doi: 10.1016/s0021-9150(02)00037-0. Atherosclerosis. 2002. PMID: 12052475 Clinical Trial.
-
Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis.J Intern Med. 2005 Nov;258(5):395-410. doi: 10.1111/j.1365-2796.2005.01556.x. J Intern Med. 2005. PMID: 16238675 Review.
-
In vivo studies of VLDL metabolism and LDL heterogeneity.Eur Heart J. 1998 Jul;19 Suppl H:H7-10. Eur Heart J. 1998. PMID: 9717058 Review.
-
Lipoprotein heterogeneity and apolipoprotein B metabolism.Arterioscler Thromb Vasc Biol. 1997 Dec;17(12):3542-56. doi: 10.1161/01.atv.17.12.3542. Arterioscler Thromb Vasc Biol. 1997. PMID: 9437204 Review.
-
The low density lipoprotein receptor prevents secretion of dense apoB100-containing lipoproteins from the liver.J Biol Chem. 2004 Jan 9;279(2):831-6. doi: 10.1074/jbc.M303057200. Epub 2003 Oct 28. J Biol Chem. 2004. PMID: 14583618
Cited by
-
Correction of dysfunctional fatty acid metabolism using peroxisome proliferator activated receptor gamma agonists.J R Soc Med. 2002;95 Suppl 42(Suppl 42):33-8. J R Soc Med. 2002. PMID: 12216325 Free PMC article. Review. No abstract available.
-
Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome.Yonsei Med J. 2006 Jun 30;47(3):405-14. doi: 10.3349/ymj.2006.47.3.405. Yonsei Med J. 2006. PMID: 16807992 Free PMC article.
-
Mechanism of action of niacin on lipoprotein metabolism.Curr Atheroscler Rep. 2000 Jan;2(1):36-46. doi: 10.1007/s11883-000-0093-1. Curr Atheroscler Rep. 2000. PMID: 11122723 Review.
-
Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women.J Endocrinol. 2010 Aug;206(2):217-24. doi: 10.1677/JOE-10-0057. Epub 2010 May 18. J Endocrinol. 2010. PMID: 20484148 Free PMC article.
-
Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes.Diabetologia. 2008 Aug;51(8):1382-90. doi: 10.1007/s00125-008-1046-4. Epub 2008 Jun 5. Diabetologia. 2008. PMID: 18535816 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources